Covid-19: a treatment authorized in the hope that it will be effective against Omicron

Aimed at those over the age of 12 at risk, the treatment is currently the only authorized treatment for people infected with Omicron.

A new anti-Covid treatment with synthetic antibodies, Xevudy, has been approved by the French health authorities, who consider it promising against infection by Omicron while other drugs have just been withdrawn because of their ineffectiveness against the new variant. Read alsoCovid-19: this treatment that remains effective against Omicron Based on the sotrovimab molecule, it will therefore be, for the time being, the only antibody treatment that can be used after a proven infection with Omicron. Another treatment of this type, Evusheld from AstraZeneca, is also considered effective against Omicron but it is given preventively, especially in people whose body is resistant to vaccination. SEE ALSO – Antivirals, corticosteroids… Dr Benjamin Rossi provides an update on treatments for serious forms Covid-19

Administration by intravenous The High Authority for Health (HAS) “ authorizes early access to a new curative treatment, Xevudy (…) of GSK ”, announced this body in a press release. This medicine is intended for people over the age of 12 who have just been infected with the coronavirus and are considered at risk of a severe form. “It is recommended to administer it within five days of the onset of symptoms”, explains the authority. Xevudy is administered intravenously. It is part of the synthetic antibody treatments, several of which have already been authorized since the start of the pandemic. But the arrival of the Omicron variant, which is more resistant to vaccines and other drugs, has made some of these treatments obsolete. The French health authorities thus ceased at the beginning of January to recommend Ronapreve from Roche in the event of infection with Omicron, even if it remains authorized against Delta, the previous dominant variant. Worse, they completely withdrew Eli Lilly’s bamlanivimab/etesivimab combination from circulation, its results also showing disappointment against Delta. Contrary to these two treatments, Xevudy «has a mechanism of action which makes it possible to hope for the maintenance of its effectiveness on the variants , including the Omicron variant”, explains the HAS. “ In vitro data suggest maintenance of the neutralizing activity of sotrovimab when that of the other available monoclonal antibodies decreases or even disappears”, she explains.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Honnan származik a koronavírus? Kínával fog össze a WHO, hogy kiderítse thumbnail

Honnan származik a koronavírus? Kínával fog össze a WHO, hogy kiderítse

MTI 2022. február 06. 14:25 Tedrosz Adhanom Gebrejeszusz első alkalommal látogatott Kínába 2020 januárja óta, amikor az első Covid-19-es esetekről szóló kínai jelentések nyomán Hszi Csin-ping kínai elnökkel egyeztetett a járvány kezeléséről. A WHO főigazgatója ezúttal a téli olimpiai játékok megnyitójára érkezett Pekingbe, ahol szombaton Li Kö-csiang kínai miniszterelnökkel folytatott megbeszélést. Tedrosz a Twitter-oldalán szombaton…
Read More
Go-ahead for $1.3bn Denver airport project thumbnail

Go-ahead for $1.3bn Denver airport project

The city council has approved Denver International Airport’s proposed plan for the Great Hall Completion, the final phase of the Great Hall project. The airport can now move forward with the design work. The approved budget for the Great Hall Completion project is US$1.3bn, which will be funded by airport revenues. Currently, Phase 2 of…
Read More

Prozesse: Fingierter Anschlag auf Restaurant?: Wirt vor Gericht

zeit.de mit Werbung Um der Nutzung mit Werbung zuzustimmen, muss JavaScript in Ihrem Browser aktiviert sein. zeit.de mit Werbung Besuchen Sie zeit.de wie gewohnt mit Werbung und Tracking. Details zum Tracking finden Sie in der Datenschutzerklärung und im Privacy Center. zeit.de Pur Nutzen Sie zeit.de mit weniger Werbung und ohne Werbetracking für 1,20 €/Woche (für…
Read More
Vacaciones en el Caribe: Volnovich habló por primera vez escándalo thumbnail

Vacaciones en el Caribe: Volnovich habló por primera vez escándalo

Vacaciones en el Caribe: Volnovich habló por primera vez escándalo La titular del PAMI reapareció este viernes en la escena pública y compartió acto con el Presidente, Alberto Fernández, en un anuncio de la entidad Por iProfesional 19/02/2022 - 13,36hs Tras la polémica por sus vacaciones en el Caribe, la titular del PAMI, Luana Volnovich…
Read More
Włochy: Wiceminister zdrowia: bez maseczek na zewnątrz od 11 lutego thumbnail

Włochy: Wiceminister zdrowia: bez maseczek na zewnątrz od 11 lutego

Drogi Użytkowniku! W związku z odwiedzaniem naszych serwisów internetowych możemy przetwarzać Twój adres IP, pliki cookies i podobne dane nt. aktywności lub urządzeń użytkownika. Jeżeli dane te pozwalają zidentyfikować Twoją tożsamość, wówczas będą traktowane dodatkowo jako dane osobowe zgodnie z Rozporządzeniem Parlamentu Europejskiego i Rady 2016/679 (RODO). Administratora tych danych, cele i podstawy przetwarzania oraz…
Read More
Index Of News
Total
0
Share